Plné znění - 261/2015 Sb.

Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2016

261/2015 Sb.

Sdělení Ministerstva zdravotnictví

INFORMACE

261

XXXXXXX

Xxxxxxxxxxxx zdravotnictví

ze dne 22. xxxx 2015

x xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx a mimořádná xxxxxxxx pro rok 2016

 

Xxxxxxxxxxxx zdravotnictví podle §80 odst. 1 xxxx. e) xxxxxx x. 258/2000 Xx., x xxxxxxx xxxxxxxxx xxxxxx x x xxxxx xxxxxxxxx souvisejících xxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, xxxxxxx xx základě xxxxxxxxxx Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2016:

1. Xxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxxxx očkování

1a) kombinovaná xxxxxxxx látka xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, nákazám xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx b (XXxXXxxXXXXXX):

Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx xxx 30 xxxxxxxxxxxxx xxxxxxxx (XX)

Xxxxxx xxxxxxxxxx1 xx méně než 40 mezinárodních jednotek (XX)

Xxxxxxxx Bordetelly pertussis:

Pertussis xxxxxxxxxx1 25 mikrogramů

Haemagglutininum xxxxxxxxxxxx1 25 mikrogramů

Pertactinum1 8 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X2,3 10 xxxxxxxxxx

Xxxxx poliomyelitis (xxxxxxxxxxxx)

xxxxx 1 (xxxx Xxxxxxx)4 40 D xxxxxxxx xxxxxxxx

xxxxx 2 (xxxx XXX-1)4 8 X xxxxxxxx xxxxxxxx

xxxxx 3 (xxxx Saukett)4 32 X xxxxxxxx xxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx xxxxx b xxxxxxxxxxxxxxx 10 mikrogramů

(polyribosylribitoli xxxxxxxx)3

xxxxxxxxx xxx tetani xxxxxxxxxx xxxx nosným xxxxxxxxx xxxxxxxxx 25 xxxxxxxxxx

XXXX

1xx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (acelulárni xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (inaktivovaná xxxxx), xxxxxx xxxxxxxxxx X, nákazám xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (DTaPHibVHBIPV)

Diphtheriae xxxxxxxxxx xx xxxx než 20 xxxxxxxxxxxxx xxxxxxxx (XX)2

Xxxxxx xxxxxxxxxx ne xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (XX)2

Xxxxxxxx Xxxxxxxxxx xxxxxxxxx

Xxxxxxxxx xxxxxxxxxx 25 xxxxxxxxxx

Xxxxxxxxxxxxxx filamentosum 25 xxxxxxxxxx

Xxxxx Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)3

xxxxx 1 (Xxxxxxx) 40 D xxxxxxxx xxxxxxxx4

xxxxx 2 (XXX-1) 8 X xxxxxxxx xxxxxxxx4

xxxxx 3 (Saukett) 32 X xxxxxxxx xxxxxxxx4

Xxxxxxxxx xxxxxxxxx xxxxxxxxxx X5 10 xxxxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx xxxx b xxxxxxxxxxxxxxx 12 xxxxxxxxxx

(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)

xxxxxxxxx cum tetani xxxxxxxxxx 22-36 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), tetanu (XXxX):

Xxxxxxxxxxx xxxxxxxxxx&xxxx;≥ 30 xxxxxxxxxxxxx xxxxxxxx

Xxxxxx anatoxinum ≥ 40 mezinárodních jednotek

Pertussis xxxxxxxxxx (XX) 25 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 25 xxxxxxxxxx

Xxxxxxxxxxx (69xX) 8 xxxxxxxxxx

XXXX

1xx) Xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxx x xxxxxxxx xxxxx (xxxxxxxxxx)

1 xxxxx (0,5 ml) xxxxxxxx:	Xxxxxxxxx 2 XX* (2 Xx)
Xxxxxxxxxxx xxxxxxxxxx
Xxxxxx xxxxxxxxxx	Xxxxxxxxx 20 XX* (5 Lf)
Pertusové xxxxxxxx
Xxxxxxxxx xxxxxxxxxx	2,5 xxxxxxxxxx
Xxxxxxxxxxxxxx filamentosum	5 xxxxxxxxxx
Xxxxxxxxxxx	3 mikrogramy
Fimbriae, typi 2 xx 3	5 xxxxxxxxxx
Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx	1,5 xx (0,33 xx xxxxxxx)

XXXX

1xx) Očkovací xxxxx xxxxx xxxxxxx, xxxxxx a dávivému xxxxx (xxxxxxxxxx komponenta) xx sníženým obsahem xxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx1 ne xxxx než 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Lf)

Tetani xxxxxxxxxx1 xx xxxx xxx 20 mezinárodních xxxxxxxx (XX) (5 Xx)

Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:

Xxxxxxxxx anatoxinum1 8 xxxxxxxxxx

Xxxxxxxxx haemagglutinum xxxxxxxxxxxx1

8 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxx xxxxxxxx proteinum1 2,5 xxxxxxxxxx

1 xxxxxxxxxxx xx xxxxxxxxxxx hydroxid xxxxxxx (XX(XX)3) 0,3 xxxxxxxxx XX3+ x xxxxxxxxxxx xxxxxxx (AIPO4) 0,2 xxxxxxxxx XX3+

1x) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxxx xxxxxxxxx Hemofilem xxxxxxxxxx x (DTaPHib):

Diphtheriae anatoxinum	min. 30 xxxxxxxxxxxxx xxxxxxxx
Xxxxxx xxxxxxxxxx	xxx. 40 mezinárodních xxxxxxxx
Xxxxxxxxx anatoxinum (XX)	25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx filamentosum (XXX)	25 xxxxxxxxxx
Xxxxxxxxxxx (69kD)	8 xxxxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx B	10 xxxxxxxxxx
xxx xxxxxxxxx xxxxxxxx	20-40 xxxxxxxxxx

1x) očkovací xxxxx xxxxx xxxxxxx vyvolaným Xxxxxxxxxxx xxxxxxxxxx xxx x:

1 xxxxx lyofilizované xxxxxxx obsahuje: Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (25 xxxxxxxxxx).

1x) xxxxxxxx xxxxx proti xxxxxx:

Xxxxxx xxxxxxxxxx ... xxx. 40 mezinárodních xxxxxxxx

1x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx X od 16 xxx a xxxx:

Xxxxxxxxx xxxxxxxxx hepatitidis B ... 20 mikrogramů

1g) xxxxxxxx látka proti xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:

Xxxxxxxxxxx virus xxxxxxxxxx (Xxxxxxx) xxx. 103,0 xxxxxxxx xxxxx pro xxxxxxxx kulturu₅₀

Parotitidis virus xxxxxxxxxx (XXX 4385) xxx. 103,7 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx₅₀

Xxxxxxxx xxxxx xxxxxxxxxx (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx₅₀

1x) očkovací látka xxxxx xxxxxx xxxxxxxx xxxxx x xxxxxxxxxxxx xxxxx:

Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Xxxxxxx) ... 40 xxxxxxxxxxx X jednotek*

Virus poliomyelitis xxxxxxxxxxx typus 2 (XXX-1) ......... 8 xxxxxxxxxxx D jednotek*

Virus xxxxxxxxxxxxx inactivatum xxxxx 3 (Saukett) ...... 32 antigenních X xxxxxxxx*

* nebo xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxx xxxxxx xxxxxxxxxxxxx xxxxxx.

1xx) xxxxxxxx látka xxxxx nákazám vyvolaným Xxxxxxxxxxxxx pneumoniae x xxxxxxxxxxxxxxx formuli:

Polysaccharidum Xxxxxxxxxxxx xxxxxxxxxx xxxxx:

1, 2, 3, 4, 5, 6X, 7X, 8, 9X, 9V, 10A, 11X, 12X, 14, 15X, 17F, 18X, 19X, 19F, 20, 22X, 23X, 33F ... 25 xxxxxxxxxx x každého xxxxxxxx

1x) xxxxxxxx xxxxx konjugovaná xxxxx pneumokokovým xxxxxxxx:

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 1

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 3

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 4

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 5

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 14

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 18X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19F

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 23F

1j) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):

Xxxxxxxxxxx anatoxinum	ne xxxx xxx 2 xxxxxxxxxxx xxxxxxxx
Xxxxxx anatoxinum	ne xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxxxxxx	8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx	8 xxxxxxxxxx
Xxxxxxxxx	2,5 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:

xxxxx 1 (xxxx Xxxxxxx)	40 D xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx XXX-1)	8 D xxxxxxxx xxxxxxxx
xxxxx 3 (xxxx Xxxxxxx)	32 X xxxxxxxx xxxxxxxx

XXXX

1xx) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx kašli (acelulární xxxxx), xxxxxx, dětské xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):

Xxxxxxxxxx xxxxxx	xxxx nebo xxxxx 2 mezinárodní xxxxxxxx (2 Xx)
Xxxxxxxxx xxxxxx	xxxx nebo rovno 20 xxxxxxxxxxxxx xxxxxxxx (5 Xx)

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxx	2,5 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxxxx	5 xxxxxxxxxx
Xxxxxxx xxxx 2+3	5 xxxxxxxxxx
Xxxxxxxxx	3 mikrogramy

-

Virus xxxxxxxxxxxxx xxxx 1 (xxxxxxxxxxxx)	40 xxxxxxxxxxx X jednotek
Virus xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx)	8 xxxxxxxxxxx D xxxxxxxx
Xxxxx xxxxxxxxxxxxx xxxx 3 (xxxxxxxxxxxx)	32 antigenních X xxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxxxxxx:

Xxxxxxxxxxxxx xxxxx attenautum (BCG) xxxxxxx Xxxxxxx 1331.....0,75 xx

&xx;2,0 x 10⁶ ≤ 8,0 x 10⁶ XXX (xxxxxx xxxxxxx)

1x) xxxxxxxx xxxxx xxxxx virové hepatitidě X xxx osoby xxxxxxxx do xxxxxxxxxxxx xxxxxxxx:

Xxxxxxxxx tegiminis xxxxxxxxxxx X xxxxxxxxxxxxxx 20 xxxxxxxxxx; adjuvans AS04C xxxxxxxxxx 3-O-deacyl-4-monofosforyl-lipid X (XXX) 50 xxxxxxxxxx x 1 dávce

1n) Xxxxxxxx látka proti xxxxxx xxxxxxxxxx X x xxxxxx xxxxxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X 10 xxxxxxxxxx x 0,5 xx xxxxxxxx

2. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx zvláštní xxxxxxxx

2x) očkovací látka xxxxx xxxxxx hepatitidě X xx formuli xxx dospělé:

Xxxxxxxxx xxxxxxxxx hepatitidis X ... 20 mikrogramů

2b) xxxxxxxx xxxxx xxxxx xxxxxxxxx

Xxxxx xxxxxx inactivatum (xxxx Xxxxxx xxxxxx XX/XX 38&xxxx;1503-3X více xxxx rovno 2,5 xxxxxxxxxxxxx xxxxxxxx v 1 xxxxx (0,5 xx)

2x) xxxxxxxx látka xxxxx xxxxxx hepatitidě X xx formuli xxx dospělé:

Hepatitis X xxxxx inactivatum

3. Xxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxx xxxxxxxx

3x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx A xx xxxxxxx xxx xxxxxxx:

Xxxxxxxxx X virus xxxxxxxxxxx

3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxx:

Xxxxx xxxxxxxxx X inactivatum

 

V xxxx 2016 x xxxxxxx xx plánovanou xxxxxxxxxx xxxxxxxx č. 537/2006 Sb., o xxxxxxxx proti infekčním xxxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, xxxxx xxxxxxxx xxxxxxxxx úpravu xxxxxxxxxxx složení očkovacích xxxxx xxx xxxxxxxxxx xxxxxxxx publikováním xxxxxx xxxxxxxxxxx xxxxxxx xxxxxx xxxxxxxxxx xxxxx xx Xxxxxx xxxxxx.

 

Xxxxxxx:

x x. XXXx. Xxxxxxx v. x.

xxxxxxxx pro xxxxxxxxxxx x xxxxx

Xxxxxxxxx

Xxxxxx xxxxxxx x. 261/2015 Xx. xxxxx xxxxxxxxx xxxx 24.10.2015.

Xx xxxxx tohoto xxxxxxxx xxxxxxxx jsou podchyceny xxxxx x xxxxxxxx xxxxxxxxxxx právním xxxxxxxxx x.:

131/2016 Sb., xxxxxx xx mění sdělení x. 261/2015 Sb., x xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx a xxxxxxxxx xxxxxxxx xxx xxx 2016

s xxxxxxxxx xx 10.5.2016

Znění jednotlivých xxxxxxxx norem xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx není xxxxxxxxxxxxx, xxxxx se xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx právního xxxxxxxx.